Table 2.
Mean value for the 30-item European Organization for Research and Treatment of Cancer Quality of Life Questionnaire scales at baseline and 6-week measurement.
| EORTC QLQ-C30a domains | Active treatment, mean (SD) | Posttreatment, mean (SD) | ||
|
|
Baseline | 6 weeks | Baseline | 6 weeks |
|
| ||||
| Global health status/quality of life | 66.67 (17.12) | 68.33 (17.48) | 62.5 (22.31) | 80.83 (9.66) |
| Physical functioning | 74.67 (30.27) | 77.33 (30.66) | 80.67 (15.85) | 87.33 (15.85) |
| Role functioning | 55 (32.44) | 60 (27.44) | 68.33 (30.88) | 81.67 (32.82) |
| Emotional functioning | 65.83 (27.34) | 63.33 (21.59) | 68.67 (28.47) | 82.67 (12.25) |
| Cognitive functioning | 55 (36.89) | 71.67 (33.38) | 63.33 (33.15) | 86.67 (17.21) |
| Social functioning | 73.33 (30.63) | 75 (25.15) | 78.33 (30.48) | 81.67 (21.44) |
| Fatigue | 50 (21.11) | 44.44 (23.42) | 42.22 (22.71) | 33.33 (13.86) |
| Nausea | 20 (31.23) | 23.33 (31.62) | 10 (11.65) | 11.67 (13.72) |
| Pain | 22 (23.64) | 25 (30.68) | 33.33 (34.25) | 13 (15.32) |
| Dyspnea | 33.33 (27.22) | 23.33 (31.62) | 16.67 (17.57) | 6.67 (14.05) |
| Insomnia | 50 (28.33) | 36.67 (39.91) | 30 (33.15) | 30 (29.19) |
| Appetite loss | 30 (36.68) | 26.67 (37.84) | 10 (16.10) | 6.67 (14.05) |
| Constipation | 6.67 (14.05) | 13.33 (32.20) | 16.67 (32.39) | 16.67 (23.57) |
| Diarrhea | 10 (22.50) | 13.33 (32.20) | 13.33 (23.31) | 6.67 (14.05) |
| Financial difficulties | 50 (39.28) | 50 (39.28) | 13.33 (23.31) | 3.33 (10.54) |
aEORTC QLQ-C30: 30-item European Organization for Research and Treatment of Cancer Quality of Life Questionnaire.